$42.08
0.541.30%
In chiusura: -
$42.08
0.000.00%
After hour: Oct 17, 4:00 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Artivion. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Artivion.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Artivion Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno agosto 19, 2025, James P Mackin, l'azienda PRESIDENT & CEO sold 12.5K condivisioni per $42.32 ciascuna.
- Il giorno agosto 14, 2025, Jean F Holloway, l'azienda SVP, GENERAL COUNSEL sold 6.38K condivisioni per $34.63 ciascuna.
Statistiche sulla proprietà per Artivion Inc
Numero di azioni emesse
47.184M
Azioni possedute dagli insider
5.545M
Percentuale posseduta dagli Insider
11.8%
Azioni possedute dagli investitori istituzionali
26.427M
Percentuale posseduta dagli investitori istituzionali
56.0%
Aug 28, 2025 | SVP, CLINICAL & MD AFFAIR | 0.00 | $27.53 | -$600.47K | SELL-OPTIONS | 0.00% | 64.20K | Aug 27 | ||
Aug 26, 2025 | SVP, GENERAL COUNSEL | 0.00 | $27.70 | -$333.40K | SELL-OPTIONS | 0.00% | 172.13K | Aug 25 | ||
Aug 19, 2025 | PRESIDENT & CEO | -12.50K | $42.32 | -$528.99K | SELL | -1.44% | 852.78K | Aug 15 | ||
Aug 14, 2025 | SVP, GENERAL COUNSEL | -6.38K | $34.63 | -$559.19K | SELL | -3.57% | 172.13K | Aug 12 | ||
Aug 14, 2025 | CHIEF COMMERCIAL OFFICER | 0.00 | $34.96 | -$188.31K | SELL-OPTIONS | 0.00% | 208.78K | Aug 12 | ||
Aug 11, 2025 | VP, CHIEF ACCOUNTING OFFICER | 0.00 | $34.05 | -$70.89K | SELL-OPTIONS | 0.00% | 146.65K | Aug 08 | ||
Jun 18, 2025 | SVP, CLINICAL & MD AFFAIR | -15.00K | $29.50 | -$442.50K | SELL | -18.94% | 64.20K | Jun 17 | ||
Jun 16, 2025 | SVP, CLINICAL & MD AFFAIR | -26.13K | $28.44 | -$743.13K | SELL | -24.81% | 79.20K | Jun 13 | ||
May 27, 2025 | SVP, GENERAL COUNSEL | -8.75K | $29.00 | -$253.69K | SELL | -4.67% | 178.51K | May 27 | ||
May 27, 2025 | DIRECTOR | -2.60K | $28.47 | -$74.03K | SELL | -7.29% | 33.06K | May 23 | ||
May 21, 2025 | SVP, GENERAL COUNSEL | -9.93K | $29.00 | -$287.85K | SELL | -5.03% | 187.26K | May 21 | ||
May 12, 2025 | SVP, CLINICAL & MD AFFAIR | -10.55K | $29.13 | -$307.27K | SELL | -9.10% | 105.33K | May 09 | ||
Mar 12, 2025 | SVP, GENERAL COUNSEL | 1.07K | $22.58 | -$14.08K | SELL-OPTIONS | 0.55% | 197.18K | Mar 11 | ||
Mar 12, 2025 | CHIEF COMMERCIAL OFFICER | 810.00 | $22.58 | -$13.69K | SELL-OPTIONS | 0.39% | 208.78K | Mar 11 | ||
Mar 10, 2025 | PRESIDENT & CEO | 102.88K | $23.16 | -$561.35K | SELL-OPTIONS | 13.49% | 865.28K | Mar 06 | ||
Mar 10, 2025 | VP, CHIEF ACCOUNTING OFFICER | 9.21K | $24.80 | -$26.00K | GRANT | 6.70% | 146.65K | Mar 06 | ||
Mar 10, 2025 | EXECUTIVE VP, CFO | 43.19K | $24.80 | -$121.76K | GRANT | 39.18% | 153.43K | Mar 06 | ||
Mar 10, 2025 | CHIEF COMMERCIAL OFFICER | 23.04K | $24.80 | -$64.94K | GRANT | 12.46% | 207.97K | Mar 06 | ||
Mar 10, 2025 | SVP, CLINICAL & MD AFFAIR | 17.64K | $24.80 | -$39.76K | GRANT | 17.95% | 115.88K | Mar 06 | ||
Mar 10, 2025 | SVP, GENERAL COUNSEL | 23.37K | $24.80 | -$52.69K | GRANT | 13.53% | 196.11K | Mar 06 | ||
Mar 06, 2025 | SVP, GENERAL COUNSEL | -472.00 | $25.29 | -$11.93K | SELL | -0.27% | 172.74K | Mar 05 | ||
Mar 05, 2025 | DIRECTOR | 2.10K | $25.30 | $53.14K | BUY | ∞ | 600.00 | Mar 05 | ||
Feb 26, 2025 | VP, CHIEF ACCOUNTING OFFICER | -3.32K | $27.31 | -$90.74K | SELL | -2.47% | 131.14K | Feb 24 | ||
Feb 26, 2025 | PRESIDENT & CEO | -42.16K | $27.31 | -$1.15M | SELL | -5.97% | 663.88K | Feb 24 | ||
Feb 26, 2025 | SVP, GENERAL COUNSEL | -5.33K | $27.31 | -$145.68K | SELL | -3.44% | 149.80K | Feb 24 | ||
Feb 26, 2025 | CHIEF COMMERCIAL OFFICER | -6.46K | $27.31 | -$176.31K | SELL | -3.86% | 160.63K | Feb 24 | ||
Feb 26, 2025 | EXECUTIVE VP, CFO | -3.26K | $27.31 | -$88.99K | SELL | -4.12% | 75.81K | Feb 24 | ||
Feb 26, 2025 | SVP, CLINICAL & MD AFFAIR | -4.69K | $27.31 | -$127.98K | SELL | -5.54% | 79.84K | Feb 24 | ||
Dec 12, 2024 | SVP, GENERAL COUNSEL | -8.07K | $30.13 | -$243.11K | SELL | -4.98% | 153.86K | Dec 11 | ||
Dec 09, 2024 | VP, CHIEF ACCOUNTING OFFICER | -4.33K | $29.66 | -$128.40K | SELL | -3.09% | 135.66K | Dec 06 | ||
Dec 04, 2024 | VP REGULATORY | -7.62K | $30.00 | -$228.54K | SELL | -18.53% | 33.50K | Dec 04 | ||
Oct 02, 2024 | VP, CHIEF ACCOUNTING OFFICER | 0.00 | $23.86 | -$57.55K | SELL-OPTIONS | 0.00% | 139.99K | Oct 01 | ||
Aug 27, 2024 | SVP, GENERAL COUNSEL | -3.17K | $26.55 | -$84.10K | SELL | -1.92% | 161.93K | Aug 26 | ||
Aug 19, 2024 | VP, HUMAN RESOURCES | -9.42K | $25.31 | -$238.43K | SELL | -21.64% | 34.12K | Aug 16 | ||
Aug 16, 2024 | SVP, GENERAL COUNSEL | -2.38K | $25.76 | -$61.39K | SELL | -1.42% | 165.10K | Aug 15 | ||
Aug 15, 2024 | DIRECTOR | -9.71K | $24.99 | -$242.63K | SELL | -22.13% | 34.16K | Aug 13 | ||
May 13, 2024 | SVP, GENERAL COUNSEL | -1.25K | $23.42 | -$29.28K | SELL | -0.74% | 167.48K | May 10 | ||
May 10, 2024 | SVP, GENERAL COUNSEL | -979.00 | $23.79 | -$23.29K | SELL | -0.58% | 168.73K | May 09 | ||
Mar 21, 2024 | SVP, CLINICAL & MD AFFAIR | -2.18K | $20.39 | -$44.51K | SELL | -2.55% | 83.30K | Mar 20 | ||
Mar 18, 2024 | VP REGULATORY | -1.46K | $20.00 | -$29.24K | SELL | -3.43% | 41.12K | Mar 15 | ||
Mar 15, 2024 | VP REGULATORY | -3.99K | $20.00 | -$79.88K | SELL | -8.58% | 42.58K | Mar 14 | ||
Mar 14, 2024 | VP, HUMAN RESOURCES | -5.00K | $19.94 | -$99.72K | SELL | -10.30% | 43.54K | Mar 12 | ||
Mar 07, 2024 | PRESIDENT & CEO | 14.62K | $18.72 | -$262.04K | GRANT | 2.12% | 705.56K | Mar 01 - Mar 05 | ||
Mar 07, 2024 | SVP, GENERAL COUNSEL | 3.34K | $18.72 | -$44.56K | GRANT | 2.01% | 169.67K | Mar 01 - Mar 05 | ||
Mar 07, 2024 | CHIEF COMMERCIAL OFFICER | 3.70K | $18.72 | -$37.86K | GRANT | 2.29% | 165.64K | Mar 01 - Mar 05 | ||
Mar 07, 2024 | VP, HUMAN RESOURCES | 2.42K | $18.72 | -$21.66K | GRANT | 5.25% | 48.50K | Mar 01 - Mar 05 | ||
Mar 07, 2024 | VP, QUALITY | 2.42K | $18.72 | -$21.66K | GRANT | 5.49% | 46.54K | Mar 01 - Mar 05 | ||
Mar 07, 2024 | VP REGULATORY | 2.42K | $18.72 | -$21.72K | GRANT | 5.48% | 46.54K | Mar 01 - Mar 05 | ||
Mar 07, 2024 | SVP, CLINICAL & MD AFFAIR | 4.22K | $18.72 | -$28.20K | GRANT | 5.19% | 85.44K | Mar 01 - Mar 05 | ||
Mar 07, 2024 | VP, CHIEF ACCOUNTING OFFICER | 2.43K | $18.72 | -$21.57K | GRANT | 1.76% | 139.96K | Mar 01 - Mar 05 | ||
Feb 29, 2024 | VP, GLOBAL OPERATIONS | -339.00 | $19.83 | -$6.72K | SELL | -1.30% | 25.69K | Feb 27 | ||
Feb 29, 2024 | VP, CHIEF ACCOUNTING OFFICER | -325.00 | $19.83 | -$6.45K | SELL | -0.24% | 137.53K | Feb 27 | ||
Feb 29, 2024 | PRESIDENT & CEO | -4.84K | $19.83 | -$95.94K | SELL | -0.70% | 690.94K | Feb 27 | ||
Feb 29, 2024 | SVP, GENERAL COUNSEL | -485.00 | $19.83 | -$9.62K | SELL | -0.29% | 166.32K | Feb 27 | ||
Feb 29, 2024 | CHIEF COMMERCIAL OFFICER | -584.00 | $19.83 | -$11.58K | SELL | -0.36% | 161.94K | Feb 27 | ||
Feb 29, 2024 | VP, QUALITY | -370.00 | $19.83 | -$7.34K | SELL | -0.83% | 44.12K | Feb 27 | ||
Feb 29, 2024 | VP, HUMAN RESOURCES | -325.00 | $19.83 | -$6.45K | SELL | -0.70% | 46.08K | Feb 27 | ||
Feb 29, 2024 | VP REGULATORY | -421.00 | $19.83 | -$8.35K | SELL | -0.95% | 44.12K | Feb 27 | ||
Feb 29, 2024 | SVP, CLINICAL & MD AFFAIR | -465.00 | $19.83 | -$9.22K | SELL | -0.57% | 81.22K | Feb 27 | ||
Feb 28, 2024 | VP, CHIEF ACCOUNTING OFFICER | 7.62K | $20.27 | -$43.91K | GRANT | 5.85% | 137.86K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | PRESIDENT & CEO | 67.74K | $20.27 | -$634.73K | GRANT | 10.79% | 695.78K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | SVP, GENERAL COUNSEL | 15.34K | $20.27 | -$58.38K | GRANT | 10.13% | 166.81K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | VP, QUALITY | 7.47K | $20.27 | -$46.93K | GRANT | 20.18% | 44.48K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | CHIEF COMMERCIAL OFFICER | 14.61K | $20.27 | -$71.23K | GRANT | 9.88% | 162.52K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | VP, HUMAN RESOURCES | 8.46K | $20.27 | -$46.89K | GRANT | 22.31% | 46.41K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | VP REGULATORY | 7.88K | $20.27 | -$48.71K | GRANT | 21.48% | 44.54K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | SVP, CLINICAL & MD AFFAIR | 12.98K | $20.27 | -$61.79K | GRANT | 18.90% | 81.69K | Feb 23 - Feb 26 | ||
Feb 28, 2024 | VP, GLOBAL OPERATIONS | -893.00 | $20.27 | -$18.10K | SELL | -3.31% | 26.07K | Feb 26 | ||
Feb 22, 2024 | SVP, GENERAL COUNSEL | -3.53K | $18.86 | -$66.54K | SELL | -2.61% | 131.86K | Feb 20 | ||
Feb 22, 2024 | VP, CHIEF ACCOUNTING OFFICER | -1.70K | $18.86 | -$31.98K | SELL | -1.37% | 122.34K | Feb 20 | ||
Feb 22, 2024 | CHIEF COMMERCIAL OFFICER | -2.56K | $18.86 | -$48.22K | SELL | -1.96% | 128.18K | Feb 20 | ||
Feb 22, 2024 | VP, QUALITY | -407.00 | $18.86 | -$7.68K | SELL | -1.38% | 29.12K | Feb 20 | ||
Feb 22, 2024 | VP, HUMAN RESOURCES | -1.70K | $18.86 | -$31.98K | SELL | -5.58% | 28.69K | Feb 20 | ||
Feb 22, 2024 | VP, GLOBAL OPERATIONS | -249.00 | $18.86 | -$4.70K | SELL | -1.28% | 19.17K | Feb 20 | ||
Feb 22, 2024 | PRESIDENT & CEO | -12.84K | $17.58 | -$393.45K | SELL | -2.33% | 539.04K | Feb 20 | ||
Jan 04, 2024 | SVP, GENERAL COUNSEL | 0.00 | $17.15 | -$36.09K | SELL-OPTIONS | 0.00% | 133.52K | Jan 02 | ||
Jan 04, 2024 | SENIOR VP, GLOBAL SALES | 0.00 | $17.15 | -$23.06K | SELL-OPTIONS | 0.00% | 128.73K | Jan 02 | ||
Dec 19, 2023 | VP, CHIEF ACCOUNTING OFFICER | 0.00 | $17.65 | -$38.87K | SELL-OPTIONS | 0.00% | 124.04K | Dec 15 | ||
Nov 29, 2023 | VP, CHIEF ACCOUNTING OFFICER | -3.85K | $17.42 | -$67.07K | SELL | -3.58% | 103.85K | Nov 27 | ||
Jun 08, 2023 | SVP, OPERATIONS | -16.25K | $15.27 | -$248.16K | SELL | -31.88% | 34.72K | Jun 06 | ||
Jun 08, 2023 | VP, HUMAN RESOURCES | -6.33K | $15.88 | -$100.48K | SELL | -17.24% | 30.39K | Jun 07 | ||
Mar 03, 2023 | SVP, OPERATIONS | 2.54K | $13.41 | -$15.03K | GRANT | 5.25% | 50.98K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | VP, QUALITY | 1.47K | $13.41 | -$11.01K | GRANT | 5.24% | 29.53K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | VP, CHIEF ACCOUNTING OFFICER | 1.59K | $13.41 | -$9.42K | GRANT | 1.50% | 107.70K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | VP, HUMAN RESOURCES | 1.59K | $13.41 | -$9.42K | GRANT | 4.52% | 36.72K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | PRESIDENT & CEO | 11.83K | $13.41 | -$133.98K | GRANT | 2.19% | 551.88K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | VP REGULATORY | 1.47K | $13.41 | -$11.06K | GRANT | 6.08% | 25.57K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | EXECUTIVE VP, COO & CFO | 3.18K | $13.41 | -$18.79K | GRANT | 0.87% | 369.78K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | SVP, CLINICAL & MD AFFAIR | 2.76K | $13.41 | -$12.16K | GRANT | 5.59% | 52.08K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | SENIOR VP, GLOBAL SALES | 2.54K | $13.41 | -$15.03K | GRANT | 2.01% | 128.73K | Mar 01 - Mar 02 | ||
Mar 03, 2023 | SVP, GENERAL COUNSEL | 2.76K | $13.41 | -$12.16K | GRANT | 2.11% | 133.52K | Mar 01 - Mar 02 | ||
Mar 01, 2023 | VP, CHIEF ACCOUNTING OFFICER | 5.18K | $12.94 | -$18.36K | GRANT | 5.13% | 106.11K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | EXECUTIVE VP, COO & CFO | 11.74K | $12.94 | -$40.03K | GRANT | 3.31% | 366.60K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | SVP, GENERAL COUNSEL | 9.57K | $12.94 | -$25.36K | GRANT | 7.89% | 130.76K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | SENIOR VP, GLOBAL SALES | 9.01K | $12.94 | -$30.96K | GRANT | 7.69% | 126.19K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | VP, QUALITY | 4.52K | $13.00 | -$26.95K | GRANT | 19.21% | 28.06K | Feb 23 - Feb 28 | ||
Mar 01, 2023 | VP REGULATORY | 5.27K | $12.94 | -$22.60K | GRANT | 27.99% | 24.10K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | PRESIDENT & CEO | 47.80K | $12.94 | -$292.79K | GRANT | 9.71% | 540.05K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | SVP, OPERATIONS | 7.76K | $12.94 | -$30.15K | GRANT | 19.07% | 48.44K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | SVP, CLINICAL & MD AFFAIR | 8.87K | $12.94 | -$30.24K | GRANT | 21.94% | 49.32K | Feb 23 - Feb 27 | ||
Mar 01, 2023 | VP, HUMAN RESOURCES | 5.00K | $12.94 | -$20.70K | GRANT | 16.58% | 35.13K | Feb 23 - Feb 27 | ||
Feb 21, 2023 | VP, CHIEF ACCOUNTING OFFICER | 985.00 | $12.16 | -$65.57K | SELL-OPTIONS | 0.99% | 100.94K | Feb 17 - Feb 19 | ||
Feb 16, 2023 | EXECUTIVE VP, COO & CFO | 4.92K | $11.73 | -$44.82K | SELL-OPTIONS | 1.39% | 358.12K | Feb 14 | ||
Feb 16, 2023 | PRESIDENT & CEO | 9.05K | $11.73 | -$75.99K | SELL-OPTIONS | 1.82% | 505.68K | Feb 14 | ||
Dec 16, 2022 | VP, CHIEF ACCOUNTING OFFICER | -5.23K | $13.43 | -$70.20K | SELL | -4.97% | 99.95K | Dec 14 | ||
Aug 18, 2022 | VP, QUALITY | -7.16K | $22.96 | -$164.41K | SELL | -36.75% | 12.32K | Aug 16 | ||
Aug 10, 2022 | SVP, OPERATIONS | -5.76K | $21.61 | -$124.51K | SELL | -20.17% | 22.81K | Aug 09 | ||
Feb 11, 2022 | PRESIDENT & CEO | 0.00 | $14.50 | -$148.94K | SELL-OPTIONS | 0.00% | 304.18K | Feb 09 - Feb 10 | ||
Feb 10, 2022 | PRESIDENT & CEO | 0.00 | $14.37 | -$71.75K | SELL-OPTIONS | 0.00% | 304.18K | Feb 08 | ||
Feb 08, 2022 | PRESIDENT & CEO | 0.00 | $14.15 | -$67.03K | SELL-OPTIONS | 0.00% | 304.18K | Feb 07 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.